SCHEMBL996316

SCHEMBL996316

CON1CCCCCC=CCCC(C(=O)O)NC(=O)C2CC(O[Si](C)(C)C(C)(C)C)C[N+]2C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3528218 0.84 MMP1 (0.34) —
SCHEMBL3811327 0.80 GAA (0.33) —
SCHEMBL996970 0.76 MCHR1 (0.33) —
SCHEMBL3814397 0.71 GAA (0.31) —
SCHEMBL2839721 0.67 JAK2 (0.33) —
SCHEMBL16242435 0.66 EPHX2 (0.33) —
SCHEMBL3814044 0.64 GAA (0.34) —
SCHEMBL3054091 0.62 — —
SCHEMBL1683129 0.61 GAA (0.36) —
SCHEMBL2837627 0.61 ALDH1A1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919898-B1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS TIBOTEC PHARM LTD (IE) 2011-01-26 — — EP disclosed
Send feedback